All In MedTech

Device Trial Radar · NCT07882277

27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery

Effect of 27-Inch and 55-Inch Endoscopic Imaging Monitors on Surgical and Postoperative Outcomes in Endometrial Cancer Surgery: A Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Oct 2026

Primary completion

Jan 2028

Study completion Feb 2028

Sponsor

Lead sponsor
Metehan UzundalGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Oct 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare the use of 27-inch and 55-inch endoscopic imaging monitors during minimally invasive surgery for women with endometrial cancer. Participants will be randomly assigned to one of the two monitor groups. All participants will undergo the same standard surgical procedure; only the monitor size used during surgery will differ. The main question is whether monitor size affects total operative time. The study will also evaluate sentinel lymph node dissection time, blood count changes, complications, infections, hospital stay, and drain-related outcomes during the first 30 days after surgery.

Conditions

  • Endometrial Cancer

Interventions

  • 27-Inch Endoscopic Imaging MonitorDevice

    Use of a 27-inch 4K-2D endoscopic imaging monitor during minimally invasive endometrial cancer surgery.

  • 55-Inch Endoscopic Imaging MonitorDevice

    Use of a 55-inch 4K-2D endoscopic imaging monitor during minimally invasive endometrial cancer surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Operative TimeTime frame: During surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Basaksehir Cam and Sakura City Hospital

    Istanbul, Istanbul, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.